US Stock MarketDetailed Quotes

DXCM DexCom

Watchlist
  • 89.070
  • +4.980+5.92%
Close Feb 14 16:00 ET
  • 89.290
  • +0.220+0.25%
Post 20:01 ET
34.80BMarket Cap62.73P/E (TTM)

DexCom Key Stats

DexCom Q4 2024 Earnings Date

Currency:USDFeb 13, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
1.10B
1.11B
+9.66M
Beat Est.
+6.70%
+7.64%
+0.88%
EPS
0.48
0.38
-0.10
Miss Est.
-22.27%
-38.71%
-21.15%
Strong Buy

Feb 17, 2025

DexCom Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 18 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 1.129B--
--2025/Q1-- / 1.017B--
Feb 13, 20252024/Q41.114B / 1.104B--
Oct 24, 20242024/Q3994.200M / 991.187M--
Jul 25, 20242024/Q21.004B / 1.037B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 1.129B--
--2025/Q1-- / 1.017B--
Feb 13, 20252024/Q41.114B / 1.104B--
Oct 24, 20242024/Q3994.200M / 991.187M--
Jul 25, 20242024/Q21.004B / 1.037B--

Unlock Free Earnings Estimates

DexCom Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Feb 17, 2025

Strong Buy

  • Buy

    93.75%
  • Hold

    6.25%
  • Sell

    0.00%

Price Target

No Data